id: P19438
gene_symbol: TNFRSF1A
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  TNFRSF1A (also known as TNFR1, p55, CD120a) encodes Tumor Necrosis Factor Receptor
  Superfamily Member 1A, a ubiquitously expressed type I transmembrane receptor that
  serves as the principal signaling receptor for soluble TNF (TNFSF2) and lymphotoxin-alpha
  (TNFSF1/LTA). The extracellular domain contains four cysteine-rich domains (CRDs),
  including a pre-ligand assembly domain (PLAD) in CRD1 that mediates ligand-independent
  receptor preassembly as homotrimers. The intracellular domain contains a death domain
  (DD) that nucleates adaptor recruitment. Upon TNF binding, the DD recruits TRADD, which
  scaffolds two distinct signaling outcomes. Complex I (membrane-proximal) comprises
  TRADD, RIPK1, TRAF2/5, cIAP1/2, and LUBAC, leading to K63/linear ubiquitination of
  RIPK1 and activation of canonical NF-kappaB and MAPK pathways that promote inflammatory
  gene expression and cell survival. When Complex I pro-survival signaling fails (e.g.,
  loss of cIAP or LUBAC activity), a cytosolic Complex II forms containing TRADD, FADD,
  and caspase-8, which triggers extrinsic apoptosis. Under conditions of caspase-8
  inhibition, RIPK1-RIPK3-MLKL assemble the necrosome to execute necroptosis. TNFR1
  ectodomain is shed by ADAM17/TACE to generate soluble TNFR1 (sTNFR1), which acts as
  a decoy receptor. The receptor also activates neutral and acid sphingomyelinases via
  its NSD and DD domains, respectively. Heterozygous pathogenic variants in the
  extracellular cysteine-rich domains cause TRAPS (TNF receptor-associated periodic
  syndrome), an autosomal dominant autoinflammatory disease. An intronic variant affecting
  alternative splicing of exon 6 produces a soluble isoform (Delta6-TNFR1) associated
  with susceptibility to multiple sclerosis.
alternative_products:
- name: 1 (FL-TNFR1)
  id: P19438-1
- name: '2'
  id: P19438-2
  sequence_note: VSP_037153
- name: 4 (Delta6-TNFR1)
  id: P19438-4
  sequence_note: VSP_044949
- name: '3'
  id: P19438-3
  sequence_note: VSP_037154
- name: '5'
  id: P19438-5
  sequence_note: VSP_047613, VSP_047614
existing_annotations:
# ===== IBA ANNOTATIONS (phylogenetically inferred) =====
- term:
    id: GO:0005031
    label: tumor necrosis factor receptor activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      TNFR1 is the defining member of the TNF receptor superfamily and its primary molecular
      function is TNF receptor activity. This is the most precise and appropriate MF term for
      this receptor (PMID:2158863, PMID:12887920).
    action: ACCEPT
    reason: >-
      TNF receptor activity is the core molecular function of TNFRSF1A. The receptor binds both
      soluble and membrane-bound TNF trimers via its extracellular cysteine-rich domains and
      transduces signal through its intracellular death domain. IBA annotation is well supported
      by phylogenetic analysis across vertebrate orthologs and extensive experimental evidence.
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          TNFR1-induced apoptosis involves two sequential signaling complexes. The initial plasma
          membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1,
          and TRAF2 and rapidly signals activation of NF-kappa B.
      - reference_id: PMID:7758105
        supporting_text: >-
          Many diverse activities of tumor necrosis factor (TNF) are signaled through TNF receptor 1
          (TNFR1). We have identified a novel 34 kDa protein, designated TRADD, that specifically
          interacts with an intracellular domain of TNFR1 known to be essential for mediating
          programmed cell death.
- term:
    id: GO:0006954
    label: inflammatory response
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      TNFR1 is a principal mediator of TNF-driven inflammatory responses. Via Complex I signaling
      (TRADD/RIPK1/TRAF2/cIAP1-2/LUBAC), it activates NF-kappaB and MAPKs to induce pro-inflammatory
      gene expression, including cytokines, chemokines, and adhesion molecules (PMID:12887920, PMID:8565075).
    action: ACCEPT
    reason: >-
      Inflammatory response is a core biological process for TNFR1. As the primary receptor for soluble
      TNF, it is the major conduit for TNF-mediated inflammation. The IBA annotation is phylogenetically
      sound and well supported by extensive literature.
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD,
          the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappa B.
      - reference_id: PMID:8565075
        supporting_text: >-
          Tumor necrosis factor (TNF) can induce apoptosis and activate NF-kappa B through signaling
          cascades emanating from TNF receptor 1 (TNFR1).
- term:
    id: GO:0045121
    label: membrane raft
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      TNFR1 has been shown to localize to membrane rafts/lipid rafts where it assembles signaling
      complexes. IBA annotation is consistent with direct experimental evidence (IDA from PMID:17010968).
    action: ACCEPT
    reason: >-
      TNFR1 localization to membrane rafts is supported by both phylogenetic inference and direct
      experimental evidence. Lipid raft partitioning is relevant to TNFR1 signaling platform
      assembly and signal transduction.
    supported_by:
      - reference_id: PMID:17010968
        supporting_text: >-
          metalloproteinase inhibition increases the proportion of ADAM17 substrates (TNF
          and its receptors TNFR1 and TNFR2) in lipid rafts
- term:
    id: GO:0043120
    label: tumor necrosis factor binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      TNF binding is a core molecular function of TNFR1. The receptor binds trimeric TNF-alpha
      (and LTA) via its extracellular cysteine-rich domains CRD2 and CRD3. Crystal structure of
      the TNF-beta-TNFR1 complex (PDB:1TNR) confirms the binding interface (PMID:8387891).
    action: ACCEPT
    reason: >-
      TNF binding is the primary ligand-recognition function of TNFR1 and is well supported by
      structural, biochemical, and phylogenetic evidence. The IBA annotation is appropriate and
      at the correct level of specificity.
    supported_by:
      - reference_id: PMID:9435233
        supporting_text: >-
          Calculation of the dissociation constant (Kd) from the association and dissociation
          rate constants determined at 37 degrees C revealed a remarkable high affinity for TNF
          binding to the 60-kDa TNF type 1 receptor (TNF-R1; Kd = 1.9 x 10(-11) M)
- term:
    id: GO:0043235
    label: receptor complex
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      TNFR1 forms homotrimeric receptor complexes via the PLAD domain even in the absence of ligand,
      and upon TNF binding assembles larger signaling complexes. IBA annotation is consistent with
      IDA evidence (PMID:23382219).
    action: ACCEPT
    reason: >-
      The receptor complex annotation reflects the well-established biology of TNFR1 homotrimerization
      and is phylogenetically conserved. More specific CC term GO:0002947 (TNFRSF complex) is also
      annotated separately.
    supported_by:
      - reference_id: PMID:23382219
        supporting_text: >-
          the PX-FERM proteins share a promiscuous ability to bind a wide array of putative
          cargo molecules, including receptor tyrosine kinases [and TNFR1 among other transmembrane cargos]
# ===== IEA ANNOTATIONS (electronic) =====
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation based on UniProt subcellular location mapping. TNFR1 transits through the Golgi
      during biosynthesis and is detected at the Golgi membrane. Consistent with IDA evidence
      (PMID:22801493).
    action: ACCEPT
    reason: >-
      Golgi membrane localization is supported by direct experimental evidence (IDA from Gregory et al. 2012)
      and reflects the transit of TNFR1 through the secretory pathway. The IEA annotation is correct and
      consistent with higher-quality evidence.
    supported_by:
      - reference_id: PMID:22801493
        supporting_text: >-
          While FL-TNFR1 localizes to the Golgi apparatus, Î”6-TNFR1 demonstrated a more
          diffuse intracellular distribution (Fig. 2), consistent with the absence of the
          Golgi-retention motif.
- term:
    id: GO:0005031
    label: tumor necrosis factor receptor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for TNF receptor activity, consistent with IBA and TAS annotations for the same term.
    action: ACCEPT
    reason: >-
      Redundant with IBA annotation but correct. IEA evidence from multiple automated methods converges
      on this core function.
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation based on UniProt subcellular location. TNFR1 ectodomain is shed by ADAM17/TACE
      producing soluble TNFR1 (sTNFR1/TBPI) found in the extracellular region. Consistent with
      multiple TAS and NAS annotations.
    action: ACCEPT
    reason: >-
      The soluble form of TNFR1 is well documented in the extracellular region. This IEA annotation
      is broader than some of the experimental evidence but not incorrect.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for plasma membrane localization, consistent with extensive TAS and IPI evidence.
    action: ACCEPT
    reason: >-
      TNFR1 is a type I transmembrane protein whose primary localization is the plasma membrane.
      This is well supported by numerous other annotations.
- term:
    id: GO:0006693
    label: prostaglandin metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation from InterPro domain IPR020419 (TNFR_1A). While TNF signaling via TNFR1 can
      indirectly influence prostaglandin metabolism through NF-kappaB-mediated induction of COX-2,
      TNFR1 does not directly participate in prostaglandin metabolism. This is a downstream pleiotropic
      effect of TNF signaling.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The link between TNFR1 and prostaglandin metabolism is indirect and downstream. TNF/TNFR1 signaling
      can activate NF-kappaB, which induces COX-2 expression, leading to prostaglandin production. However,
      annotating TNFR1 directly to prostaglandin metabolic process overstates its involvement. TNFR1 does
      not catalyze or directly regulate prostaglandin synthesis. MADD (which binds TNFR1) was shown to
      activate ERK and phospholipase A2, providing a link to arachidonic acid release, but this is still
      indirect (PMID:9115275).
    supported_by:
      - reference_id: PMID:9115275
        supporting_text: >-
          These data indicate that MADD links TNFR1 with MAP kinase activation and arachidonic acid release
          and provide further insight into the mechanisms by which TNF exerts its pleiotropic effects.
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for apoptotic process. TNFR1 is indeed a key death receptor that signals apoptosis
      via Complex II (TRADD/FADD/caspase-8). However, the more specific term GO:0008625 (extrinsic
      apoptotic signaling pathway via death domain receptors) is already annotated.
    action: ACCEPT
    reason: >-
      While the more specific death-domain-mediated extrinsic apoptosis term is also annotated, this
      broader IEA annotation is not wrong. TNFR1 is a classical death receptor and apoptosis induction
      is a core function. It is acceptable for IEA to be broader than more specific experimental annotations.
- term:
    id: GO:0006954
    label: inflammatory response
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation from InterPro domain, consistent with IBA and ISS annotations for the same term.
    action: ACCEPT
    reason: >-
      Redundant with IBA but correct. Inflammatory response is a core process for TNFR1.
- term:
    id: GO:0007165
    label: signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation from InterPro death domain (IPR000488). Signal transduction is indeed a function
      of TNFR1 but this is very generic. More specific terms like TNF-mediated signaling pathway
      are also annotated.
    action: ACCEPT
    reason: >-
      While very broad, signal transduction is not incorrect for a signaling receptor. More specific
      terms are annotated elsewhere. It is acceptable for IEA annotations to use broader terms.
- term:
    id: GO:0010468
    label: regulation of gene expression
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning. TNFR1 signaling through NF-kappaB does regulate
      gene expression, but this is a very general downstream consequence of TNFR1 signaling rather
      than a direct function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Regulation of gene expression is an extremely broad term. While TNFR1 does activate NF-kappaB
      which is a transcription factor, annotating the receptor itself to "regulation of gene expression"
      is too distant from the receptor's direct molecular role. The annotation chain is receptor ->
      adaptors -> kinase cascades -> IKK -> NF-kappaB -> gene expression. More specific annotations
      (positive regulation of NF-kappaB signaling, positive regulation of transcription by RNA pol II)
      are already present.
- term:
    id: GO:0010557
    label: positive regulation of macromolecule biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning. Very generic biological process that is an indirect
      downstream consequence of TNFR1 signaling.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is an extremely broad term. While TNFR1 signaling via NF-kappaB can promote transcription
      and thus macromolecule biosynthesis, this annotation provides no useful specificity about
      TNFR1 function. More specific terms are already annotated.
- term:
    id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation consistent with IMP and TAS annotations for the same core signaling pathway.
    action: ACCEPT
    reason: >-
      TNF-mediated signaling pathway is a core process for TNFR1 and is the most specific pathway
      term. Consistent with multiple higher-evidence annotations.
- term:
    id: GO:0050793
    label: regulation of developmental process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning. Very broad developmental process term.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      While TNFR1 has roles in developmental apoptosis (valve development, morphogenesis), those
      are annotated with more specific terms. This very broad IEA term does not add useful information
      and is likely derived from indirect pathway annotations.
- term:
    id: GO:0051239
    label: regulation of multicellular organismal process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning. Extremely broad term.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is one of the broadest possible BP annotations. While technically not wrong, it provides
      no useful information about TNFR1 function. More specific process terms are already annotated.
# ===== PROTEIN BINDING IPI ANNOTATIONS =====
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11684708
  review:
    summary: >-
      IPI evidence for interaction with TRADD (Q15628). TRADD is the primary adaptor recruited
      to the TNFR1 death domain and is central to both NF-kappaB and apoptosis signaling
      (PMID:7758105, PMID:8565075).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The interaction with TRADD via death domains is the
      defining signaling mechanism of TNFR1. This should be annotated with a more specific
      MF term such as GO:0005031 (tumor necrosis factor receptor activity) which encompasses
      the adaptor recruitment function, or ideally a death domain binding term.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
    supported_by:
      - reference_id: PMID:7758105
        supporting_text: >-
          We have identified a novel 34 kDa protein, designated TRADD, that specifically interacts
          with an intracellular domain of TNFR1 known to be essential for mediating programmed
          cell death.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12887920
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375). TNF binding is the primary ligand-receptor
      interaction for TNFR1 (PMID:12887920).
    action: MODIFY
    reason: >-
      The interaction with TNF is already captured by the more specific GO:0043120 (tumor necrosis
      factor binding). Protein binding is uninformative for this well-characterized receptor-ligand
      interaction.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          TNFR1-induced apoptosis involves two sequential signaling complexes. The initial plasma
          membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1,
          and TRAF2
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:14743216
  review:
    summary: >-
      IPI evidence for interactions with TNF (P01375), ubiquitin (P0CG47), and MON2 (Q7Z3U7)
      from a large-scale TNF-alpha/NF-kappaB pathway mapping study.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The TNF interaction is captured by GO:0043120. The ubiquitin
      interaction likely reflects TNFR1 complex ubiquitination (RIPK1 ubiquitination in Complex I).
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16611992
  review:
    summary: >-
      IPI evidence for interactions with RIPK1 (Q13546) and TRADD (Q15628). These are core
      signaling adaptors in the TNFR1 Complex I.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. RIPK1 and TRADD recruitment to the TNFR1 death domain
      is the defining mechanism of TNFR1 signaling.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18022363
  review:
    summary: >-
      IPI evidence for interaction with RIPK1 (Q13546).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. RIPK1 interaction via the death domain is integral to
      TNFR1 signaling.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19524513
  review:
    summary: >-
      IPI evidence for interactions with RIPK1 (Q13546) and TRADD (Q15628).
    action: MODIFY
    reason: >-
      Protein binding is uninformative for these well-characterized death domain-mediated interactions.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19641494
  review:
    summary: >-
      IPI evidence for interactions with TRADD (Q15628) and RFK (Q969G6). The RFK interaction
      is noteworthy as RFK (riboflavin kinase) has been reported to bind TNFR1 and may play
      a role in TNF-induced superoxide production.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The TRADD interaction is part of core signaling. The
      RFK interaction is interesting but protein binding does not capture the functional significance.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19781631
  review:
    summary: >-
      IPI evidence for interactions with RIPK1 (Q13546) and TRADD (Q15628) in context of
      PAR2-mediated inhibition of TNF-stimulated JNK.
    action: MODIFY
    reason: >-
      Protein binding is uninformative for core TNFR1 adaptor interactions.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20080539
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375).
    action: MODIFY
    reason: >-
      TNF binding is captured by GO:0043120. Protein binding is uninformative.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20103630
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375) from a study on DR5 peptides.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding is captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:22028622
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:22817896
  review:
    summary: >-
      IPI evidence for interaction with RIPK1 (Q13546).
    action: MODIFY
    reason: >-
      Protein binding is uninformative for this core signaling interaction.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23955153
  review:
    summary: >-
      IPI evidence for interactions with TNF (P01375) and TRADD (Q15628). This paper (Li et al. 2013,
      Nature) demonstrated that bacterial NleB1 GlcNAcylates Arg-376 in the TNFR1 death domain,
      blocking death domain interactions.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF/TRADD interactions are captured by more specific terms.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24070898
  review:
    summary: >-
      IPI evidence for interactions with TNF (P01375) and progranulin/GRN (P28799). Progranulin
      was reported to bind CRD2 and CRD3 of TNFR1, competing with TNF.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The TNF interaction is captured by GO:0043120. The progranulin
      interaction is interesting but protein binding does not capture the specificity.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25241761
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375) from an in situ proximity ligation assay study.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25911380
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:2848815
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375). This is one of the earliest papers on
      TNFR1, demonstrating purification of the receptor by immunoaffinity chromatography
      based on TNF binding.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The TNF binding is captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32822567
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375) from a large-scale IgSF interactome study.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      IPI evidence for interactions with TNF (P01375), ubiquitin (P0CG47), RIPK1 (Q13546),
      and TRADD (Q15628) from a dual proteome-scale network study.
    action: MODIFY
    reason: >-
      Protein binding is uninformative for these well-characterized interactions.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35922511
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375) from a physical wiring diagram of the
      human immune system.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:36179048
  review:
    summary: >-
      IPI evidence for interaction with TNF (P01375).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. TNF binding captured by GO:0043120.
    proposed_replacement_terms:
      - id: GO:0043120
        label: tumor necrosis factor binding
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:7758105
  review:
    summary: >-
      IPI evidence for interaction with TRADD (Q15628). This is the landmark paper by Hsu et al. (1995)
      identifying TRADD as the primary TNFR1 adaptor that signals cell death and NF-kappaB activation.
    action: MODIFY
    reason: >-
      Protein binding is uninformative for this critical signaling interaction. TRADD binding to
      the TNFR1 death domain is the initiating step in all TNFR1 signaling cascades.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
    supported_by:
      - reference_id: PMID:7758105
        supporting_text: >-
          We have identified a novel 34 kDa protein, designated TRADD, that specifically interacts
          with an intracellular domain of TNFR1 known to be essential for mediating programmed cell
          death. Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and
          activation of NF-kappa B.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:8565075
  review:
    summary: >-
      IPI evidence for interaction with TRADD (Q15628). Hsu et al. (1996) showed that TRADD-TRAF2
      and TRADD-FADD interactions define two distinct TNFR1 signaling pathways.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The TRADD interaction is part of core receptor signaling.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
    supported_by:
      - reference_id: PMID:8565075
        supporting_text: >-
          TRADD directly interacts with TRAF2 and FADD, signal transducers that activate NF-kappa B
          and induce apoptosis, respectively.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:8621670
  review:
    summary: >-
      IPI evidence for interaction with TRADD (Q15628) from mutational analysis of the TRADD death domain.
    action: MODIFY
    reason: >-
      Protein binding is uninformative for the core TNFR1-TRADD death domain interaction.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:8943045
  review:
    summary: >-
      IPI evidence for interaction with TRADD (Q15628).
    action: MODIFY
    reason: >-
      Protein binding is uninformative for the core TNFR1-TRADD interaction.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
# ===== IDENTICAL PROTEIN BINDING =====
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:14743216
  review:
    summary: >-
      IPI evidence for TNFR1 self-interaction (P19438 with P19438). TNFR1 homotrimerizes
      through the PLAD domain in CRD1, which is essential for receptor preassembly and
      signaling competence.
    action: ACCEPT
    reason: >-
      TNFR1 homotrimerization via the PLAD domain is a well-established feature of TNFR1
      biology. Self-association is required for proper receptor function and is biologically
      meaningful, making identical protein binding an appropriate annotation in this case.
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:21988832
  review:
    summary: >-
      IPI evidence for TNFR1 self-interaction from a large-scale liver interactome study.
    action: ACCEPT
    reason: >-
      Consistent with the known PLAD-mediated homotrimerization of TNFR1.
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:7758105
  review:
    summary: >-
      IPI evidence for TNFR1 self-interaction from the landmark TRADD paper (Hsu et al. 1995).
    action: ACCEPT
    reason: >-
      TNFR1 homotrimerization is well-established and required for signaling.
# ===== IEA ENSEMBL/ISS ORTHOLOG-TRANSFERRED ANNOTATIONS =====
- term:
    id: GO:0003176
    label: aortic valve development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse Tnfrsf1a (P25118) via Ensembl Compara. Mouse knockout
      studies show TNFR1 role in cardiac valve development.
    action: KEEP_AS_NON_CORE
    reason: >-
      Aortic valve development is a specific developmental phenotype observed in mouse knockouts.
      While plausible based on ortholog evidence, this is a pleiotropic downstream effect of TNFR1
      signaling in a specific tissue context, not a core function. ISS annotation for the same term
      is also present.
- term:
    id: GO:0003177
    label: pulmonary valve development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse Tnfrsf1a (P25118) via Ensembl Compara.
    action: KEEP_AS_NON_CORE
    reason: >-
      Similar to aortic valve development, this is a pleiotropic developmental phenotype from
      mouse knockout studies, not a core function of TNFR1.
- term:
    id: GO:0003332
    label: negative regulation of extracellular matrix constituent secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse Tnfrsf1a. TNF/TNFR1 signaling can modulate ECM
      turnover, but this is a downstream tissue-specific effect.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a downstream consequence of TNF/TNFR1 signaling in specific tissue contexts
      (e.g., cardiac fibrosis). Not a core function.
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for cell surface localization. TNFR1 is a type I transmembrane protein
      present at the cell surface.
    action: ACCEPT
    reason: >-
      Cell surface localization is correct and consistent with TNFR1 being a transmembrane
      receptor that binds extracellular TNF.
- term:
    id: GO:0010467
    label: gene expression
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. Very broad term.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Gene expression is extremely broad. TNFR1 signaling activates NF-kappaB which induces
      gene expression, but this is too distant from the receptor's direct function. More
      specific terms (positive regulation of transcription by RNA polymerase II) already
      capture this.
- term:
    id: GO:0010614
    label: negative regulation of cardiac muscle hypertrophy
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNFR1 has been implicated in cardiac remodeling
      through mouse knockout studies.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a tissue-specific physiological role of TNFR1 in cardiac biology, a downstream
      pleiotropic effect rather than a core function.
- term:
    id: GO:0038023
    label: signaling receptor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. Signaling receptor activity is correct but less
      specific than GO:0005031 (TNF receptor activity).
    action: ACCEPT
    reason: >-
      While less specific than TNF receptor activity, signaling receptor activity is correct
      for TNFR1 and it is acceptable for IEA annotations to be at a broader level of specificity.
- term:
    id: GO:0043123
    label: positive regulation of canonical NF-kappaB signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNFR1 Complex I signaling activates canonical
      NF-kappaB through IKK complex recruitment and IkappaB phosphorylation (PMID:12887920).
    action: ACCEPT
    reason: >-
      Positive regulation of canonical NF-kappaB signaling is a core output of TNFR1 Complex I.
      This is well supported by extensive literature and is one of the primary signaling
      outcomes of TNF/TNFR1 engagement.
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD,
          the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappa B.
- term:
    id: GO:0045121
    label: membrane raft
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse, consistent with IBA and IDA annotations.
    action: ACCEPT
    reason: >-
      Redundant with IBA and IDA but correct. Membrane raft localization is experimentally
      verified for TNFR1.
- term:
    id: GO:0048143
    label: astrocyte activation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNF/TNFR1 signaling can activate astrocytes
      in the CNS, but this is a cell-type-specific downstream effect.
    action: KEEP_AS_NON_CORE
    reason: >-
      Astrocyte activation is a specific physiological response in the CNS context. While
      TNFR1 does play roles in neuroinflammation, this is a cell-type-specific pleiotropic
      effect rather than a core function.
- term:
    id: GO:0060856
    label: establishment of blood-brain barrier
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNFR1 has been implicated in blood-brain barrier
      regulation through mouse studies.
    action: KEEP_AS_NON_CORE
    reason: >-
      Blood-brain barrier establishment is a tissue-specific developmental/physiological role
      for TNFR1 in the CNS. Not a core function of the receptor.
- term:
    id: GO:0071222
    label: cellular response to lipopolysaccharide
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. LPS signaling via TLR4 induces TNF production,
      which then signals through TNFR1. This is a secondary response where TNFR1 responds to
      autocrine/paracrine TNF produced in response to LPS, not a direct response to LPS.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      TNFR1 does not directly respond to LPS. Rather, LPS signals through TLR4 to induce TNF
      production, and the secreted TNF then activates TNFR1. Annotating TNFR1 to "cellular
      response to lipopolysaccharide" conflates the TNF response with the LPS response. The
      receptor responds to TNF, not LPS.
- term:
    id: GO:1900119
    label: positive regulation of execution phase of apoptosis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNFR1 can trigger apoptosis via Complex II
      (TRADD/FADD/caspase-8), leading to execution phase apoptosis.
    action: ACCEPT
    reason: >-
      TNFR1 is a classical death receptor and positive regulation of the execution phase
      of apoptosis is a direct consequence of Complex II signaling. This is a core function.
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          In a second step, TRADD and RIP1 associate with FADD and caspase-8, forming a cytoplasmic
          complex (complex II).
- term:
    id: GO:1902339
    label: positive regulation of apoptotic process involved in morphogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation transferred from mouse. TNFR1-mediated apoptosis plays roles in
      developmental morphogenesis, particularly in cardiac valve formation.
    action: KEEP_AS_NON_CORE
    reason: >-
      Developmental apoptosis during morphogenesis is a tissue-specific function. While
      plausible based on mouse data, this is not a core function of TNFR1.
# ===== EXPERIMENTAL CC ANNOTATIONS =====
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IPI
  original_reference_id: PMID:8387891
  review:
    summary: >-
      IPI evidence from the crystal structure of the TNFR1-TNF-beta complex (Banner et al. 1993),
      which characterized the extracellular domain of the membrane-bound receptor.
    action: ACCEPT
    reason: >-
      Plasma membrane localization is fundamental for TNFR1 as a type I transmembrane receptor.
# ===== NAS/TAS PROCESS ANNOTATIONS =====
- term:
    id: GO:0007250
    label: activation of NF-kappaB-inducing kinase activity
  evidence_type: NAS
  original_reference_id: PMID:33824270
  review:
    summary: >-
      NAS annotation for activation of NF-kappaB-inducing kinase (NIK) activity. TNFR1 Complex I
      signals primarily through the canonical NF-kappaB pathway (IKK-dependent). NIK activation
      is more typically associated with the non-canonical NF-kappaB pathway, which is primarily
      triggered by TNFR2, CD40, BAFFR, and LTbetaR rather than TNFR1.
    action: UNDECIDED
    reason: >-
      NIK is primarily associated with the non-canonical NF-kappaB pathway, which is not the
      principal pathway activated by TNFR1. While there may be some context-dependent activation,
      this annotation may be inaccurate for TNFR1. Without access to the referenced publication
      (PMID:33824270), I cannot fully evaluate whether the evidence supports NIK activation
      specifically through TNFR1. The canonical pathway via IKK complex is the primary NF-kappaB
      activation mechanism for TNFR1.
- term:
    id: GO:0007259
    label: cell surface receptor signaling pathway via JAK-STAT
  evidence_type: IMP
  original_reference_id: PMID:21410936
  review:
    summary: >-
      IMP evidence for TNFR1 involvement in JAK-STAT signaling. TNF has been reported to
      activate STAT signaling in some contexts, though this is not the primary signaling pathway.
    action: KEEP_AS_NON_CORE
    reason: >-
      JAK-STAT signaling is not a primary output of TNFR1. The core signaling pathways are
      NF-kappaB (Complex I) and apoptosis/necroptosis (Complex II/necrosome). JAK-STAT activation
      by TNFR1 may occur in specific cellular contexts but is not a core function. The IMP evidence
      from PMID:21410936 supports this as a real but non-core function.
- term:
    id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:21410936
  review:
    summary: >-
      IMP evidence for TNF-mediated signaling pathway. This is the most specific and appropriate
      pathway term for TNFR1.
    action: ACCEPT
    reason: >-
      TNF-mediated signaling pathway is the primary pathway for TNFR1 and this IMP annotation
      appropriately captures this core function.
- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IMP
  original_reference_id: PMID:21410936
  review:
    summary: >-
      IMP evidence that TNFR1 signaling leads to positive regulation of transcription by RNA
      polymerase II, presumably through NF-kappaB activation.
    action: KEEP_AS_NON_CORE
    reason: >-
      TNFR1 signaling activates NF-kappaB, which in turn drives transcription. This is a
      downstream consequence of the core signaling pathway. While real, it is several steps
      removed from the receptor's direct function.
# ===== ISS ANNOTATIONS =====
- term:
    id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse Tnfrsf1a (MGI:1314884). Core pathway for TNFR1.
    action: ACCEPT
    reason: >-
      Consistent with IMP and TAS annotations for the same term. Core pathway.
- term:
    id: GO:0038023
    label: signaling receptor activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse ortholog. Correct but less specific than GO:0005031.
    action: ACCEPT
    reason: >-
      Signaling receptor activity is correct for TNFR1. Less specific than TNF receptor activity
      but not wrong.
# ===== REACTOME TAS PLASMA MEMBRANE ANNOTATIONS =====
# These are all TAS evidence from Reactome pathway annotations placing TNFR1 at the plasma membrane.
# They are redundant (all the same GO term) but from different Reactome reaction IDs.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3371353
  review:
    summary: >-
      TAS from Reactome reaction "Soluble TNF-alpha binds TNFR1". Plasma membrane is correct.
    action: ACCEPT
    reason: >-
      Correct localization. Part of Reactome TNF signaling pathway annotation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357757
  review:
    summary: TAS from Reactome "BIRC(cIAP1/2) ubiquitinates RIPK1". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for Complex I signaling events.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357776
  review:
    summary: TAS from Reactome "TNFR1 complex recruits IKK". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for Complex I signaling events.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357780
  review:
    summary: TAS from Reactome "TNFR1 complex recruits BIRC2/3". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for Complex I signaling events.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357845
  review:
    summary: TAS from Reactome "K63polyUb-RIPK1 is deubiquitinated". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for TNFR1 complex regulation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357860
  review:
    summary: TAS from Reactome "TNFR1 complex recruits TAK1 complex". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for Complex I signaling events.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357904
  review:
    summary: TAS from Reactome "TNFR1 complex binds LUBAC". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for Complex I signaling events.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5357928
  review:
    summary: TAS from Reactome "CLIP3 and CYLD bind TNF signaling complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for TNFR1 complex regulation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5626953
  review:
    summary: TAS from Reactome "TNF-alpha:TNFR1 binds DENN/MADD". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for ceramide production pathway.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5626981
  review:
    summary: TAS from Reactome for neutral sphingomyelinase pathway. Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5626982
  review:
    summary: TAS from Reactome for NSMAF-RACK1 binding. Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5626988
  review:
    summary: TAS from Reactome for NSMAF binding. Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5634221
  review:
    summary: TAS from Reactome "TRAF1 binds TRAF2 within TNFR1 signaling complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for Complex I.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5669097
  review:
    summary: TAS from Reactome "LTA trimer binds TNFRSF1A,1B,14". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for LTA binding to TNFR1 at the plasma membrane.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693055
  review:
    summary: TAS from Reactome "TAX1BP1:A20 binds RIPK1 complexes". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for TNFR1 complex regulation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693108
  review:
    summary: TAS from Reactome "A20 ubiquitinates RIPK1". Plasma membrane is correct.
    action: ACCEPT
    reason: Correct localization for TNFR1 complex regulation.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-83582
  review:
    summary: TAS from Reactome "TRADD:TRAF2:RIP1 dissociates from TNFR1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for Complex I to Complex II transition.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-83656
  review:
    summary: TAS from Reactome "TNF:TNFR1 binds TRADD, TRAF2 and RIPK1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for Complex I assembly.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-83660
  review:
    summary: TAS from Reactome "Membrane-anchored TNF-alpha binds TNFR1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization for membrane-TNF binding.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9793679
  review:
    summary: TAS from Reactome "LUBAC ubiquitinates RIPK1 at K627". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9793680
  review:
    summary: TAS from Reactome "OPTN binds polyUb-RIPK1 within TNFR1 complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9796342
  review:
    summary: TAS from Reactome "MIB2 binds RIPK1 within TNFR1 complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9796346
  review:
    summary: TAS from Reactome "MIB2 ubiquitinates RIPK1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9796379
  review:
    summary: TAS from Reactome "CYLD:SPATA2:LUBAC binds TNFR1 complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9817362
  review:
    summary: TAS from Reactome for LUBAC-mediated RIPK1 ubiquitination. Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9817397
  review:
    summary: TAS from Reactome "TBK1/IKBKE phosphorylate RIPK1 at T189". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9817400
  review:
    summary: TAS from Reactome "CYLD hydrolyses K63polyUb on RIPK1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9817411
  review:
    summary: TAS from Reactome "TBK1/IKBKE binds Met1-polyUb in TNFR1 complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9818789
  review:
    summary: TAS from Reactome "CHUK/IKBKB phosphorylate RIPK1 at S25". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9818975
  review:
    summary: TAS from Reactome "CYLD hydrolyses M1polyUb on RIPK1". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9824874
  review:
    summary: TAS from Reactome "OPTN recruits CYLD to TNFR1 complex". Plasma membrane correct.
    action: ACCEPT
    reason: Correct localization.
# ===== ADDITIONAL IPI/EXPERIMENTAL ANNOTATIONS =====
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:8985253
  review:
    summary: >-
      IPI evidence for interaction with CRMA/p78560 (BAG4/SODD). BAG4 (Silencer of Death Domains)
      binds to the TNFR1 death domain and prevents spontaneous signaling in the absence of ligand
      (PMID:9915703).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. BAG4/SODD interaction with the TNFR1 death domain
      is a specific regulatory mechanism that keeps the receptor silenced until ligand binding.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0002947
    label: tumor necrosis factor receptor superfamily complex
  evidence_type: TAS
  original_reference_id: PMID:24966471
  review:
    summary: >-
      TAS annotation placing TNFR1 as part of the TNF receptor superfamily complex.
    action: ACCEPT
    reason: >-
      This is the most specific CC term for TNFR1. It accurately reflects that TNFR1 forms
      homotrimeric complexes and assembles multi-protein signaling complexes.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: TAS
  original_reference_id: PMID:24966471
  review:
    summary: >-
      TAS annotation for membrane localization. Very general term.
    action: ACCEPT
    reason: >-
      While very general, membrane localization is correct for this transmembrane protein.
      More specific terms (plasma membrane, Golgi membrane) are also annotated.
- term:
    id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  evidence_type: TAS
  original_reference_id: PMID:24966471
  review:
    summary: >-
      TAS annotation for TNF-mediated signaling pathway from ARUK-UCL curation.
    action: ACCEPT
    reason: >-
      Core pathway annotation for TNFR1. Consistent with IMP and ISS annotations.
- term:
    id: GO:0043120
    label: tumor necrosis factor binding
  evidence_type: IPI
  original_reference_id: PMID:9435233
  review:
    summary: >-
      IPI evidence for TNF binding from ARUK-UCL curation, with evidence of binding to TNF
      (P01375).
    action: ACCEPT
    reason: >-
      TNF binding is a core molecular function of TNFR1. Well supported by structural and
      biochemical data.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24130170
  review:
    summary: >-
      IPI evidence for interactions with RIPK1 (Q13546), TRADD (Q15628), and SH3RF2 (Q8TEC5).
      Kim et al. (2014) showed SH3RF2 facilitates RIPK1 and TRADD recruitment to TNFR1.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The interactions describe core TNFR1 signaling complex
      assembly.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
# ===== ISS ANNOTATIONS (BHF-UCL curated) =====
- term:
    id: GO:0003176
    label: aortic valve development
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse Tnfrsf1a (P25118) by BHF-UCL curators.
    action: KEEP_AS_NON_CORE
    reason: >-
      Developmental process from mouse knockout data. Not a core function of TNFR1.
      Duplicate of IEA annotation.
- term:
    id: GO:0003177
    label: pulmonary valve development
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse. Duplicate of IEA annotation.
    action: KEEP_AS_NON_CORE
    reason: >-
      Developmental process from mouse knockout data. Not a core function.
- term:
    id: GO:0003332
    label: negative regulation of extracellular matrix constituent secretion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse. Duplicate of IEA annotation.
    action: KEEP_AS_NON_CORE
    reason: >-
      Tissue-specific downstream effect. Not a core function.
- term:
    id: GO:1902339
    label: positive regulation of apoptotic process involved in morphogenesis
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse. Duplicate of IEA annotation.
    action: KEEP_AS_NON_CORE
    reason: >-
      Developmental apoptosis. Not a core function, but a real pleiotropic role.
# ===== EXTRACELLULAR REGION ANNOTATIONS =====
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6785047
  review:
    summary: >-
      TAS from Reactome IL-10 signaling pathway. The soluble TNFR1 ectodomain is found in
      the extracellular region.
    action: ACCEPT
    reason: >-
      The soluble form of TNFR1 (sTNFR1) is present in the extracellular region and is
      relevant to IL-10 signaling regulation of inflammatory mediators.
# ===== IMP ANNOTATIONS (UniProt curated) =====
- term:
    id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:25816133
  review:
    summary: >-
      IMP evidence for TNF-mediated signaling pathway from PMID:25816133.
    action: ACCEPT
    reason: >-
      Core pathway annotation supported by mutant phenotype evidence.
- term:
    id: GO:0072659
    label: protein localization to plasma membrane
  evidence_type: IMP
  original_reference_id: PMID:25816133
  review:
    summary: >-
      IMP evidence that TNFR1 is involved in protein localization to the plasma membrane.
      This likely reflects TNFR1 trafficking or its role in recruiting other proteins to
      the plasma membrane via signaling complex assembly.
    action: KEEP_AS_NON_CORE
    reason: >-
      While TNFR1 does assemble signaling complexes at the plasma membrane, "protein
      localization to plasma membrane" is not a core function. It may reflect a secondary
      observation in the experiment.
- term:
    id: GO:1903140
    label: regulation of establishment of endothelial barrier
  evidence_type: IMP
  original_reference_id: PMID:25816133
  review:
    summary: >-
      IMP evidence for TNFR1 role in endothelial barrier regulation. TNF/TNFR1 signaling
      is known to increase endothelial permeability, relevant to inflammation.
    action: KEEP_AS_NON_CORE
    reason: >-
      Endothelial barrier regulation is a physiologically important but tissue-specific
      downstream effect of TNF/TNFR1 signaling. Not a core function of the receptor.
# ===== ADDITIONAL IPI ANNOTATIONS =====
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24440909
  review:
    summary: >-
      IPI evidence for interaction with Q9D1X0 (a mouse protein). Cross-species interaction data.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. Cross-species interaction evidence.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
# ===== IDA ANNOTATIONS =====
- term:
    id: GO:0043235
    label: receptor complex
  evidence_type: IDA
  original_reference_id: PMID:23382219
  review:
    summary: >-
      IDA evidence for TNFR1 as part of a receptor complex, from structural biology study on
      PX-FERM protein interactions with transmembrane cargo.
    action: ACCEPT
    reason: >-
      TNFR1 forms homotrimeric receptor complexes and is part of larger signaling complexes.
      Direct experimental evidence supports this annotation.
- term:
    id: GO:0008625
    label: extrinsic apoptotic signaling pathway via death domain receptors
  evidence_type: TAS
  original_reference_id: PMID:8612133
  review:
    summary: >-
      TAS annotation for the extrinsic apoptotic signaling pathway via death domain receptors.
      TNFR1 is a classical death domain receptor that triggers extrinsic apoptosis through
      Complex II (TRADD/FADD/caspase-8) (PMID:12887920, PMID:8565075).
    action: ACCEPT
    reason: >-
      This is one of the most precise and appropriate BP annotations for TNFR1. The extrinsic
      apoptotic pathway via death domain receptors is a core function of TNFR1, well supported
      by the landmark studies on TRADD, FADD, and caspase-8 recruitment.
    supported_by:
      - reference_id: PMID:12887920
        supporting_text: >-
          In a second step, TRADD and RIP1 associate with FADD and caspase-8, forming a
          cytoplasmic complex (complex II).
      - reference_id: PMID:8565075
        supporting_text: >-
          A FADD mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor
          of TNF-induced apoptosis, but does not inhibit NF-kappa B activation.
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IDA
  original_reference_id: PMID:22801493
  review:
    summary: >-
      IDA evidence for Golgi membrane localization from Gregory et al. (2012, Nature). This
      study on the MS-associated TNFRSF1A variant showed TNFR1 in the Golgi.
    action: ACCEPT
    reason: >-
      Direct experimental evidence for Golgi localization. TNFR1 transits through the Golgi
      during biosynthesis. Some disease-associated variants cause ER/Golgi retention.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10848577
  review:
    summary: >-
      IPI evidence for interaction with STAT1 (P42224). Bhattacharyya et al. showed Stat1
      as a component of the TNFR1-TRADD signaling complex.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The STAT1 interaction is part of TNFR1 signaling
      complex assembly.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: IDA
  original_reference_id: PMID:13130484
  review:
    summary: >-
      IDA evidence for extracellular space localization. The soluble form of TNFR1 (sTNFR1)
      is found in the extracellular space after ADAM17/TACE-mediated ectodomain shedding.
    action: ACCEPT
    reason: >-
      sTNFR1 is well documented in extracellular fluids (serum, urine) and acts as a decoy
      receptor. This is a physiologically important localization.
- term:
    id: GO:0050728
    label: negative regulation of inflammatory response
  evidence_type: IMP
  original_reference_id: PMID:13130484
  review:
    summary: >-
      IMP evidence for negative regulation of inflammatory response. This likely reflects
      the anti-inflammatory role of soluble TNFR1 (sTNFR1) which sequesters TNF, or the
      context-dependent regulation where TNFR1 signaling can dampen inflammation through
      specific mechanisms.
    action: KEEP_AS_NON_CORE
    reason: >-
      While TNFR1 is primarily pro-inflammatory (through NF-kappaB activation), the soluble
      form can have anti-inflammatory effects by sequestering TNF. This dual role is context
      dependent and the negative regulation aspect is not a core function of the receptor.
      Additionally, some TRAPS-associated variants show paradoxical inflammatory effects
      suggesting complex regulation.
- term:
    id: GO:0071260
    label: cellular response to mechanical stimulus
  evidence_type: IEP
  original_reference_id: PMID:19593445
  review:
    summary: >-
      IEP evidence for cellular response to mechanical stimulus. Expression pattern evidence
      indicates TNFR1 expression changes in response to mechanical stimulus.
    action: KEEP_AS_NON_CORE
    reason: >-
      IEP evidence only shows expression change in response to mechanical stimulus, not that
      TNFR1 directly mediates the response. This is a weak evidence code and the annotation
      reflects a secondary observation rather than a core function.
- term:
    id: GO:0045121
    label: membrane raft
  evidence_type: IDA
  original_reference_id: PMID:17010968
  review:
    summary: >-
      IDA evidence for membrane raft localization. Direct experimental evidence supporting
      TNFR1 partitioning into lipid rafts.
    action: ACCEPT
    reason: >-
      Direct experimental evidence for membrane raft localization, consistent with IBA
      and IEA annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9115275
  review:
    summary: >-
      IPI evidence for interaction with MADD (Q8WXG6). Schievella et al. (1997) identified MADD
      as a death domain protein that interacts with TNFR1 and activates MAP kinase.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. MADD interaction with the TNFR1 death domain is a specific
      signaling interaction linking TNFR1 to MAP kinase activation.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
    supported_by:
      - reference_id: PMID:9115275
        supporting_text: >-
          We have used the yeast interaction trap to isolate a protein, MADD, that associates with
          the death domain of TNFR1 through its own C-terminal death domain.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15465831
  review:
    summary: >-
      IPI evidence for interaction with BABAM2/BRE (Q9NXR7). Li et al. (2004) showed BRE
      inhibits mitochondrial apoptotic pathway as a death receptor-associated anti-apoptotic
      protein.
    action: MODIFY
    reason: >-
      Protein binding is uninformative. The BABAM2 interaction is a specific regulatory
      interaction in the TNFR1 signaling context.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
- term:
    id: GO:0005031
    label: tumor necrosis factor receptor activity
  evidence_type: TAS
  original_reference_id: PMID:2158863
  review:
    summary: >-
      TAS annotation from the original cloning paper by Schall et al. (1990) which described
      molecular cloning and expression of the human TNF receptor.
    action: ACCEPT
    reason: >-
      TNF receptor activity is the core molecular function. This TAS annotation from the
      original cloning paper is foundational.
- term:
    id: GO:0006954
    label: inflammatory response
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse ortholog. Inflammatory response is a core process.
    action: ACCEPT
    reason: >-
      Consistent with IBA and IEA annotations. Core function.
- term:
    id: GO:0019221
    label: cytokine-mediated signaling pathway
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse. Cytokine-mediated signaling is correct for TNFR1
      but less specific than TNF-mediated signaling pathway.
    action: ACCEPT
    reason: >-
      TNFR1 is indeed a cytokine receptor that mediates cytokine signaling. While less specific
      than GO:0033209, this is not incorrect.
- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse for positive regulation of transcription by RNA
      polymerase II, reflecting NF-kappaB-driven gene expression.
    action: KEEP_AS_NON_CORE
    reason: >-
      Downstream consequence of TNFR1 signaling via NF-kappaB. Real but not a core function
      of the receptor itself.
- term:
    id: GO:0050729
    label: positive regulation of inflammatory response
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation transferred from mouse for positive regulation of inflammatory response.
    action: ACCEPT
    reason: >-
      TNFR1 signaling via NF-kappaB drives pro-inflammatory gene expression, making positive
      regulation of inflammatory response a core function. This is more specific than "inflammatory
      response" and accurately reflects the pro-inflammatory role.
# ===== IEP ANNOTATIONS =====
- term:
    id: GO:0043123
    label: positive regulation of canonical NF-kappaB signal transduction
  evidence_type: IEP
  original_reference_id: PMID:12761501
  review:
    summary: >-
      IEP evidence from a large-scale screen that identified human genes activating NF-kappaB
      and MAPK pathways.
    action: ACCEPT
    reason: >-
      While IEP is a weaker evidence code, this annotation is fully consistent with the
      extensive mechanistic evidence for TNFR1 activation of canonical NF-kappaB signaling.
      The annotation is correct and supported by numerous other annotations.
# ===== NAS/TAS EXTRACELLULAR REGION =====
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: NAS
  original_reference_id: PMID:12189246
  review:
    summary: >-
      NAS annotation for extracellular region. The soluble form of TNFR1 is present in the
      extracellular region.
    action: ACCEPT
    reason: >-
      Consistent with IDA evidence for extracellular space and IEA for extracellular region.
      The soluble form (sTNFR1) is well documented in extracellular fluids.
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: PMID:1698610
  review:
    summary: >-
      TAS annotation from Nophar et al. (1990) which demonstrated that the TNFR1 cDNA encodes
      both cell surface and soluble forms of the receptor.
    action: ACCEPT
    reason: >-
      This is one of the earliest demonstrations of the soluble TNFR1 ectodomain in the
      extracellular region.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: PMID:1698610
  review:
    summary: >-
      TAS annotation from Nophar et al. (1990). Plasma membrane localization for the full-length
      receptor.
    action: ACCEPT
    reason: >-
      One of the original papers demonstrating TNFR1 at the plasma membrane. Core localization.
# ===== ADDITIONAL PROTEIN BINDING ANNOTATIONS =====
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11684708
  review:
    summary: >-
      Second IPI entry for interaction with TRADD (Q15628) from the same PMID, curated by
      UniProt (vs. the IntAct entry above).
    action: MODIFY
    reason: >-
      Protein binding is uninformative. Duplicate annotation from different curation groups.
    proposed_replacement_terms:
      - id: GO:0005031
        label: tumor necrosis factor receptor activity
# ===== NEW ANNOTATIONS (suggested by reviewer) =====
- term:
    id: GO:0070266
    label: necroptotic process
  evidence_type: TAS
  original_reference_id: PMID:12887920
  review:
    summary: >-
      TNFR1-mediated signaling is the best-characterized inducer of necroptosis. When
      caspase-8 is inhibited, RIPK1/RIPK3/MLKL assemble a necrosome downstream of TNFR1
      Complex II, executing programmed necrotic cell death. This is a core signaling outcome
      of TNFR1 activation under specific conditions (PMID:12887920).
    action: NEW
    reason: >-
      Necroptosis is a well-established signaling outcome downstream of TNFR1, particularly
      when caspase-8 is inhibited. The GO definition of GO:0070266 explicitly references
      death domain receptor signaling and RIPK1/RIPK3/MLKL dependence. This is missing from
      the existing annotation set and represents a core function of the receptor under
      specific signaling contexts.
    additional_reference_ids:
      - PMID:25816133
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:2158863
  title: Molecular cloning and expression of a receptor for human tumor necrosis factor.
  findings:
    - statement: Original cloning of TNFR1 (p55) demonstrating TNF receptor activity
- id: PMID:7758105
  title: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa
    B activation.
  findings:
    - statement: >-
        Identified TRADD as the primary adaptor for TNFR1 death domain that signals both
        apoptosis and NF-kappaB activation
- id: PMID:8565075
  title: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1
    signal transduction pathways.
  findings:
    - statement: >-
        Demonstrated that TRADD-TRAF2 activates NF-kappaB while TRADD-FADD induces apoptosis,
        defining the bifurcation of TNFR1 signaling at TRADD
- id: PMID:8612133
  title: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.
  findings: []
- id: PMID:9115275
  title: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis
    factor receptor and activates mitogen-activated protein kinase.
  findings:
    - statement: >-
        Identified MADD as a death domain protein interacting with TNFR1, linking the receptor
        to MAP kinase activation and arachidonic acid release
- id: PMID:12887920
  title: Induction of TNF receptor I-mediated apoptosis via two sequential signaling
    complexes.
  findings:
    - statement: >-
        Defined the two-complex model: Complex I (TNFR1/TRADD/RIP1/TRAF2) at the membrane for
        NF-kappaB activation, and cytosolic Complex II (TRADD/RIP1/FADD/caspase-8) for apoptosis
- id: PMID:22801493
  title: TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple
    sclerosis.
  findings:
    - statement: >-
        Identified MS-associated TNFRSF1A variant causing exon 6 skipping, producing soluble
        Delta6-TNFR1 isoform. Showed Golgi membrane localization of TNFR1
- id: PMID:9435233
  title: The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.
  findings: []
- id: PMID:24966471
  title: Tumor necrosis factor alpha - a link between neuroinflammation and excitotoxicity.
  findings: []
- id: PMID:25816133
  title: "Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-\u03BAB-dependent phases."
  findings: []
- id: PMID:13130484
  title: Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
  findings:
    - statement: >-
        Characterized TRAPS-associated TNFRSF1A variants and showed soluble TNFR1 in
        extracellular space
- id: PMID:17010968
  title: The shedding activity of ADAM17 is sequestered in lipid rafts.
  findings: []
- id: PMID:15465831
  title: A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway.
  findings: []
- id: PMID:24130170
  title: SH3RF2 functions as an oncogene by mediating PAK4 protein stability.
  findings: []
- id: PMID:10848577
  title: Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation.
  findings: []
- id: PMID:1698610
  title: Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.
  findings:
    - statement: >-
        Demonstrated that TNFR1 cDNA encodes both membrane-bound and soluble receptor forms
- id: PMID:21410936
  title: Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L.
  findings: []
- id: PMID:23382219
  title: Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.
  findings: []
- id: PMID:9915703
  title: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
  findings:
    - statement: >-
        Identified BAG4/SODD as a silencer that binds the TNFR1 death domain to prevent
        spontaneous signaling
- id: file:human/TNFRSF1A/TNFRSF1A-deep-research-falcon.md
  title: Deep research synthesis of TNFRSF1A literature
# === IPI protein binding PMIDs ===
- id: PMID:11684708
  title: Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD.
  findings: []
- id: PMID:14743216
  title: A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.
  findings: []
- id: PMID:16611992
  title: Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1.
  findings: []
- id: PMID:18022363
  title: IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
  findings: []
- id: PMID:19524513
  title: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.
  findings: []
- id: PMID:19641494
  title: Riboflavin kinase couples TNF receptor 1 to NADPH oxidase.
  findings: []
- id: PMID:19781631
  title: Proteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - A novel paradigm for G(q/11) linked GPCRs.
  findings: []
- id: PMID:20080539
  title: The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase.
  findings: []
- id: PMID:20103630
  title: Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.
  findings: []
- id: PMID:22028622
  title: "Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor \u03B1-induced necroptosis."
  findings: []
- id: PMID:22817896
  title: The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis.
  findings: []
- id: PMID:23955153
  title: Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.
  findings: []
- id: PMID:24070898
  title: Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.
  findings: []
- id: PMID:25241761
  title: Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
  findings: []
- id: PMID:25911380
  title: "The seventh zinc finger motif of A20 is required for the suppression of TNF-\u03B1-induced apoptosis."
  findings: []
- id: PMID:2848815
  title: Human tumor necrosis factor-alpha receptor. Purification by immunoaffinity chromatography and initial characterization.
  findings: []
- id: PMID:32822567
  title: A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  findings: []
- id: PMID:35922511
  title: A physical wiring diagram for the human immune system.
  findings: []
- id: PMID:36179048
  title: Novel biochemical, structural, and systems insights into inflammatory signaling revealed by contextual interaction proteomics.
  findings: []
# === IDA / ISS PMIDs ===
- id: PMID:8621670
  title: Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD.
  findings: []
- id: PMID:8943045
  title: The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.
  findings: []
- id: PMID:21988832
  title: Toward an understanding of the protein interaction network of the human liver.
  findings: []
- id: PMID:8387891
  title: "Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation."
  findings: []
- id: PMID:33824270
  title: "Membrane lymphotoxin-\u03B1(2)\u03B2 is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist."
  findings: []
- id: PMID:8985253
  title: RAIDD is a new 'death' adaptor molecule.
  findings: []
- id: PMID:24440909
  title: "A novel role for the apoptosis inhibitor ARC in suppressing TNF\u03B1-induced regulated necrosis."
  findings: []
- id: PMID:19593445
  title: Expression of the Bcl-2 protein BAD promotes prostate cancer growth.
  findings: []
- id: PMID:12761501
  title: Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.
  findings: []
- id: PMID:12189246
  title: Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding.
  findings: []
# === Reactome pathway references ===
- id: Reactome:R-HSA-3371353
  title: Reactome pathway - TNFR1-induced signaling
  findings: []
- id: Reactome:R-HSA-5357757
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357776
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357780
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357845
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357860
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357904
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5357928
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5626953
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5626981
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5626982
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5626988
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5634221
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5669097
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5693055
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-5693108
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-83582
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-83656
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-83660
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9793679
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9793680
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9796342
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9796346
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9796379
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9817362
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9817397
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9817400
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9817411
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9818789
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9818975
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-9824874
  title: Reactome pathway - TNFR1 signaling
  findings: []
- id: Reactome:R-HSA-6785047
  title: Reactome pathway - TNFR1 signaling
  findings: []
core_functions:
- description: >-
    TNFR1 binds trimeric TNF-alpha and lymphotoxin-alpha via its extracellular
    cysteine-rich domains (CRD2-CRD3), functioning as the primary signaling receptor
    for soluble TNF. Upon ligand binding, recruits TRADD via its death domain to
    nucleate Complex I, activating NF-kappaB and MAPK pathways for pro-inflammatory
    and pro-survival gene expression.
  molecular_function:
    id: GO:0005031
    label: tumor necrosis factor receptor activity
  directly_involved_in:
  - id: GO:0033209
    label: tumor necrosis factor-mediated signaling pathway
  - id: GO:0007249
    label: canonical NF-kappaB signal transduction
  - id: GO:0006954
    label: inflammatory response
  locations:
  - id: GO:0009986
    label: cell surface
  - id: GO:0005886
    label: plasma membrane
  supported_by:
  - reference_id: PMID:12887920
    supporting_text: >-
      TNFR1-induced apoptosis involves two sequential signaling complexes. The initial
      plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD,
      the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappa B.
  - reference_id: PMID:7758105
    supporting_text: >-
      Many diverse activities of tumor necrosis factor (TNF) are signaled through TNF
      receptor 1 (TNFR1). We have identified a novel 34 kDa protein, designated TRADD,
      that specifically interacts with an intracellular domain of TNFR1 known to be
      essential for mediating programmed cell death.
- description: >-
    When Complex I pro-survival signaling fails (e.g., loss of cIAP or LUBAC activity),
    TRADD and RIPK1 dissociate from the receptor to form cytosolic Complex II with FADD
    and caspase-8, triggering extrinsic apoptosis. Under caspase-8 inhibition, RIPK1-RIPK3-MLKL
    assemble the necrosome for necroptosis.
  molecular_function:
    id: GO:0005031
    label: tumor necrosis factor receptor activity
  directly_involved_in:
  - id: GO:0097191
    label: extrinsic apoptotic signaling pathway
  - id: GO:0070266
    label: necroptotic process
  locations:
  - id: GO:0005886
    label: plasma membrane
  supported_by:
  - reference_id: PMID:12887920
    supporting_text: >-
      A second complex (complex II) is formed after TRADD and RIP1 associate with FADD
      and caspase-8, and the modified RIP1 in complex II keeps caspase-8 in an inactive
      state. When NF-kappa B is activated by complex I, expression of antiapoptotic
      genes are activated, which are sufficient to block the pro-apoptotic activity of
      complex II.
  - reference_id: PMID:8565075
    supporting_text: >-
      A FADD mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor
      of TNF-induced apoptosis, but does not inhibit NF-kappa B activation. Thus, these
      two TNFR1-TRADD signaling cascades appear to bifurcate at TRADD.
